Login / Signup

Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.

Lesca M HoldtAnika StahringerKristina SassGarwin PichlerNils A KulakWolfgang WilfertAlexander KohlmaierAndreas HerbstBernd H NorthoffAlexandros NicolaouGabor GäbelFrank BeutnerMarkus ScholzJoachim ThieryKiran MusunuruKnut KrohnMatthias MannDaniel Teupser
Published in: Nature communications (2016)
Circular RNAs (circRNAs) are broadly expressed in eukaryotic cells, but their molecular mechanism in human disease remains obscure. Here we show that circular antisense non-coding RNA in the INK4 locus (circANRIL), which is transcribed at a locus of atherosclerotic cardiovascular disease on chromosome 9p21, confers atheroprotection by controlling ribosomal RNA (rRNA) maturation and modulating pathways of atherogenesis. CircANRIL binds to pescadillo homologue 1 (PES1), an essential 60S-preribosomal assembly factor, thereby impairing exonuclease-mediated pre-rRNA processing and ribosome biogenesis in vascular smooth muscle cells and macrophages. As a consequence, circANRIL induces nucleolar stress and p53 activation, resulting in the induction of apoptosis and inhibition of proliferation, which are key cell functions in atherosclerosis. Collectively, these findings identify circANRIL as a prototype of a circRNA regulating ribosome biogenesis and conferring atheroprotection, thereby showing that circularization of long non-coding RNAs may alter RNA function and protect from human disease.
Keyphrases